Cosmo Pharmaceuticals N.V.
CMOPFOTCHealthcare● Active
$90.00
$-1.14(-1.25%)
Market Cap$1.5B
P/E Ratio—
52W High$169.9
52W Low$64.37
Cosmo Pharmaceuticals N.V.（CMOPF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CMOPF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.10B | $0.27B | $0.09B | $0.10B | $0.07B |
| Cost of Revenue | $0.06B | $0.02B | $0.04B | $0.02B | $0.02B |
| Gross Profit | $0.05B | $0.25B | $0.05B | $0.08B | $0.05B |
| Gross Margin %(computed) | 46.53% | 92.55% | 57.60% | 81.62% | 76.73% |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.00B | $0.02B | $0.02B | $0.01B |
| G&A Expenses | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.06B | $0.10B | $0.05B | $0.06B | $0.02B |
| Operating Income | ($0.01B) | $0.15B | $0.01B | $0.03B | $0.01B |
| Operating Margin %(computed) | -10.00% | 55.81% | 6.62% | 27.48% | 17.06% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | ($0.00B) | $0.15B | $0.00B | $0.02B | $0.02B |
| Income Tax Expense | $0.00B | $0.02B | $0.01B | $0.01B | $0.00B |
| Net Income | ($0.00B) | $0.13B | ($0.00B) | $0.02B | $0.02B |
| Net Margin %(computed) | -3.46% | 49.94% | -5.32% | 16.87% | 33.30% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.23 | $8.15 | $-0.31 | $1.05 | $1.29 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.00B | $0.17B | $0.02B | $0.05B | $0.02B |
| EBITDA Margin %(computed) | 2.25% | 62.11% | 21.23% | 45.79% | 27.37% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · EUR · B
深入了解Cosmo Pharmaceuticals N.V.
关于Cosmo Pharmaceuticals N.V.（CMOPF）损益表
Cosmo Pharmaceuticals N.V.（CMOPF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CMOPF实现营收$0.10B，毛利润$0.05B（毛利率46.53%），净利润($0.00B)（净利率-3.46%）。
常见问题
CMOPF · 4 问Cosmo Pharmaceuticals N.V.（CMOPF）2025财年营收为$0.10B，同比down60.7%。
CMOPF revenueCMOPF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08